Chemours (CC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Chemours

    NYSE: CC · Real-Time Price · USD
    16.36
    -0.13 (-0.79%)
    At close: Sep 24, 2025, 3:59 PM
    16.41
    0.31%
    After-hours: Sep 24, 2025, 07:55 PM EDT

    Chemours Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.78B 6.03B 6.79B 6.34B
    Cost of Revenue
    		 4.63B 4.72B 5.18B 4.96B
    Gross Profit
    		 1.15B 1.31B 1.62B 1.38B
    Operating Income
    		 458M -92M 913M 888M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 127M -318M 741M 676M
    Net Income
    		 86M -238M 578M 608M
    Selling & General & Admin
    		 585M 1.29B 710M 592M
    Research & Development
    		 109M 108M 118M 107M
    Other Expenses
    		 14M n/a n/a n/a
    Operating Expenses
    		 708M 1.4B 828M 699M
    Interest Expense
    		 264M 208M 163M 185M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 5.33B 6.11B 6.01B 5.66B
    Income Tax Expense
    		 41M -81M 163M 68M
    Shares Outstanding (Basic)
    		 149.49M 148.91M 155.36M 164.94M
    Shares Outstanding (Diluted)
    		 150.01M 148.91M 158.3M 168.7M
    EPS (Basic)
    		 0.58 -1.6 3.72 3.69
    EPS (Diluted)
    		 0.57 -1.6 3.65 3.60
    EBITDA
    		 692M 197M 1.2B 1.21B
    EBIT
    		 391M -110M 793M 691M
    Depreciation & Amortization
    		 301M 307M 291M 317M

    Add to Watchlist